Diabetes conferences | Endocrinology Conferences | CME accredited | Global Meetings| Rome | Italy| Europe | USA | 2017

Theme: Applying Science and Technology to Fight Diabetes

Diabetes Global 2017

Scientific Program

Renowned Speakers

Michael Yafi
University of Texas USA

Douglas Ishii
Colorado State University USA

Lixin Li
Central Michigan University, USA

Nicolette N. Houreld
University of Johannesburg, South Africa

Rachel Knott
Robert Gordon University UK

Omo Ojo
University of Greenwich UK

Belma Turan
Ankara University Turkey

VladimÃr Å trbÃ¡k
Slovak Medical University Slovakia
Slovakia

Mohammad Alhadj Ali
Cardiff University School of Medicine
UK

Udaya M Kabadi
University of Iowa
USA

Malcolm Carruthers
Centre for Mens Health
UK

Diabetes Global 2017

The exciting and innovative program brought together national and international experts to promote the exchange of the latest clinical practices and cutting edge research in diabetes. State-of-the-Art lectures, free communication sessions and clinical and scientific educational symposia, were appreciated by the 2016 attendees. With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 16^th Global Diabetes Conference & Medicare Expo (Diabetes Global 2017) as a continuum of our previous successful conference. Diabetes Global 2017 will be held in Rome, Italy during March 22-23, 2017. The conference will focus on Applying Science and Technology to Fight Diabetes.

The program organizing committee consists of members from all three societies and endeavors to present you with the latest and most exciting data from these respective fields with a range of international and national leading speakers. The benefits of this large scale collaborative meeting include: broader content areas, efficiency in meeting attendance and costs for delegates and trade partners, a more diverse variety of sessions, and increased attendees. Our scientific program includes invited plenary presentations, symposia and seminars, meet-the-professor sessions, basic and clinical abstract presentations, young investigator awards, and interactive poster sessions. Our speakers are drawn from a truly international profile, with themes in contemporary Diabetes and its related disorders and Therapies.

Why to Attend?

The meeting will provide many opportunities to network and discuss science and medicine, ensure equity of opportunity, find new funding and research opportunities, and build collaborations and contacts with international colleagues. We are sure that you will find this to be a truly exciting meeting presenting both the breadth and depth of clinical and basic research. Trade partners will have exposure to more areas of specialties in Diabetes and Endocrinology. World Class Speakers and Fresh New Talent from across the Globe in Health Industry gather in this world congress.

Target Audience

Diabetologists

Endocrinologists

Doctors

Researchers

Physicians

Business Professionals

Academic Professionals

Students

Scientists

Medical and Pharma Companies

Medical Colleges and Hospitals

Diabetes Societies and Associations

We look forward to seeing you in Italy!

Track 1: Physiology of diabetes

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not a complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies

American Diabetes Association, USA; Diabetic Association of India, India; Saudi Diabetes and Endocrine Association, Saudi Arabia; Nepal Diabetic Society, Nepal; Australian Diabetes Society, Australia; Diabetes Technology Society, USA; Diabetes Australia, Australia; Austrian Diabetes Association, Austria; Finnish Diabetes Association, Finland; Association of Juvenile Diabetes, USA

Track 2: Diagnosis of Diabetes

Diabetes may be analysed based on both plasma glucose criteria or A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highle discussed in ADA annual meeting and ADA sessions

13^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies

Estonian Diabetes Association, Estonia; Finnish Diabetes Association, Finland; French Diabetics Association, France; German Diabetes Union, Germany; Hellenic Diabetes Association, Greece; Hong Kong Diabetes Federation, Hong Kong; Icelandic Diabetic Association, Iceland; Diabetes Federation of Ireland, Ireland; The Diabetes Association, Itlay; Japan Diabetes Society, Japan

Track 3: Diabetic Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods.The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e the idiographic approach. Case studies permits an investigator to investigate a topic in far more detailed and minute way. The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies

Netherlands Diabetes Association, Netherlands; Diabetes New Zealand, New Zealand; Norwegian Diabetes Association, Norway; Diabetes Philippines, Philippines; Polish Diabetes Association, Poland; Diabetic Association of Portugal, Portugal; Diabetic Society of Singapore, Singapore; Diabetes South Africa, South Africa; Spanish Diabetes Society, Spain; Swedish Diabetes Association, Sweden

Track 4: Treatment of diabetes

Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes and direct our choices in choosing optimal therapies for type 1 and type 2 diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies

Swiss Diabetes Society, Switzerland; Diabetes UK, UK; Korean Diabetes Association, Korea; Lithuanian Diabetes Association, Lithuana; Luxembourg Diabetes Association, Luxemberg; Maltese Diabetes Association, Malta; Mexican Diabetes Federation, Mexico; IDS Immunology Of Diabetes Society, USA; Philippine Society of Endocrinology and Metabolism, Philippines; Union of Diabetics of Czech Republic, Czech Republic

Track 5: Diabetes in Market

Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about sixty million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes has been growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.

Related Societies

Canadian Diabetes Association, Canada; Juvenile Diabetes Foundation of Chile, Chile; Diabetological Colombian Federation, Columbia; Croatian Diabetes Association, Croatia; Union of Diabetics of Czech Republic, Czech Republic; Diabetes Association of Jamaica, Jamaica; Diabetic Foot Society of India, India; American Association of Clinical Endocrinologists, USA; Society for Endocrinology, UK; Endocrine Society, USA

Track 6: Complementary and Alternative Medicine

Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.

Related Societies

European Society of Endocrinology, UK; The American Association of Endocrine Surgeons, USA; Society for Reproductive Endocrinology and Infertility, USA; Saudi Diabetes and Endocrine Association, Saudi Arabia; Endocrine Society Of India, India; The Endocrine Society of Australia, Australia; British Association of Endocrine and Thyroid Surgeons, UK; Pediatric Endocrinology Nursing Society, USA; Pediatric Endocrine Society, USA; European Society for Paediatric Endocrinology, UK

Track 7: Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications. Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

Related Societies

Pediatric Endocrinology and Diabetes Associates, USA; American Society of Hypertension, USA; American Thyroid Association, USA; Thyroid Foundation of Canada, Canada; European Thyroid Association, Germany; British Thyroid Foundation, UK; Albania Diabetes Association, Albania; Argentina Diabetes Society, Argentina; Bahrain Diabetic Association, Bahrain; Diabetic Association of Bangladesh, Bangladesh

Track 8: Endocrinology

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitors many important function of our body. When the hormones exits the glands they arrive the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulates the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; Diabetes Conferences, September 15- September 17, Berlin, Germany, 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016,USA ; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE;15th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; Mid-Atlantic AACE 13th Annual meeting on Endocrinology Sep 25-26 2015, USA; AACE New England annual meeting on endocrinology November 14th 2015, Marlborough; Pediatric endocrine society annual meeting April 29 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK, Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Related Societies

Association Belge du Diabetes, Belgium; Bermuda Diabetes Association, Bermuda; Bulgarian Diabetes Association, Bulgaria; Cameroon Diabetes Association, Cameroon; Association Diabetes Quebec, Canada; Diabetes Society of the Chinese Medical Association, China; Colombia Diabetes Association, Columbia; Costa Rica Association For Endocrinology, Diabetes and Nutrition, Costa Rica; Cyprus Diabetes Association, Cyprus

Track 9: Diabetes and its Complications

Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications. Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.

Related Societies

Czech Diabetes Society, Czech Republic; Diabetesforeningen, Denmark; Dominican Diabetes Association, Rosesu; National Institute of Diabetes, Dominican Republic; The Egyptian Union of Diabetes Association, Egypt; Estonia Diabetes Association, Estonia; Ethiopian Diabetes Association, Ethiopia; Fiji National Diabetes Foundation, Fiji; Finnish Diabetes Association, Finland; Association Franquise des Diabetiques, France

Track 10: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually diabetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;3^rd Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Related Societies

Georgian Diabetes Federation, Georgia; German Diabetes Union, Germany; Ghana Diabetes Association, Ghana; Hellenic Diabetologic Association, Greece; Grenada Diabetes Association, Greneda; Society for the Study of Endocrinology, Hong Kong; Hungarian Diabetes Association, Hungary; Indonesia Diabetes Association, Indonesia; Irish Diabetes Association, Ireland; Israel Diabetes Association, Israel

Track 11: Genetics and Diabetes

Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.

Related Societies

Italian Society of Diabetology, Italy; Diabetes Association of Jamaica, Jamaica; Japan Diabetes Society, Japan; Kenya Diabetes Association, Kenya; Korean Diabetes Association, Korea; Lebanese Diabetes Association, Lebanon; Lithuania Diabetes Association, Lithuana; Luxemburg Diabetes Association, Luxemberg; Malagasy Diabetes Association, Madagascar; Malaysia Diabetes Association, Malaysia

Track 12: T herapy for Diabetes

Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells. The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Related Societies

Maltese Diabetes Association, Malta; Mexico Diabetic Federation, Mexico; Dutch Diabetes Association, Netherlands; Diabetes New Zealand, New Zealand; Diabetes Association of Nigeria, Nigeria; Norwegian Diabetes Association, Norway; Diabetes Association of Pakistan, Pakistan; Ameen Diabetic Association, Pakistan; Panamanian Diabetes Association, Panama; Paraguary Society of Diabetology, Paraguary

Track 13: Market Analysis of Diabetic Products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Related Societies

Juvenile Diabetes Association of Peru, Peru; Philippine Diabetes Association, Philippines; Polish Diabetes Association, Poland; Portuguese Diabetes Association, Portugal; Puerto Rico Endocrinology & Diabetology Society, Puerto Rico; Society of Diabetes, Nutrition & Metabolic Diseases, Romania; Saudi Diabetes & Endocrine Association, Saudi Arabia; Diabetic Society of Singapore, Singapore; Society of Endocrine, Metabolism & Diabetes of Southern Africa, South Africa; Diabetes South Africa, South Africa

Track 14: Emerging Focus on Diabetes

Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology has observed the expansion of newer generation of nanomedicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.

Related Societies

Spanish Diabetic Society, Spain; Diabetes Association of Sri Lanka, Sri Lanka; Sudan Diabetic Association, Sudan; Swedish Diabetic Association, Sweden; Swedish Endocrine Society, Sweden; Swiss Diabetes Association, Switzerland; Syria Diabetes Association, Syria; Diabetes Association of Thailand, Thailand; The Diabetes Association of Trinidad and Tabago, Trindad and Tobago; Tunisian Diabetic Association, Tunisia

Track 15: Diabetic Foot and Ankle

Foot problems are a big risk. All people with diabetes should monitor their feet. If you don't, the consequences can be severe, including amputation. Minor injuries become major emergencies before you know it. With a diabetic foot, a wound as small as a blister from wearing a shoe that's too tight can cause a lot of damage. Diabetes may also decrease your blood flow, so your injuries can be slow to heal. If your wound is not healing, it's at risk for infection. As a diabetic, your infection may spread quickly, and if you have any loss of sensation (neuropathy) you may not recognize that the problem is getting worse. People whose diabetes is not properly controlled tend to have more foot problems than nondiabetics. Having diabetes is not a sentence to developing problems with the feet. Lifestyle and physical activity plays an important role. The patient’s profession can be an indicator to determine what their prognosis may be. Types of diabetic foot and ankle problems seen are multifactorial. The most common complication is peripheral neuropathy. It is often because patients with long-standing diabetes, who have diabetic peripheral neuropathy, may not have adequate feeling in one or both feet or ankles, to know early that something is wrong.

Related Societies

Turkish Diabetes Association, Turkey; British Diabetes Association, UK; American Diabetes Association, USA; The Juvenile Diabetes Research Foundation, USA; Diabetics Association of Uruguay, Uruguay; Venezuela Diabetes Association, Venezuela; Venezuela Endocrine Society, Venezuela, Diabetes Association of Zambia, Zambia; Endocrine Society of India, India; American Association of Clinical Endocrinologists, USA

Track 16: Diabetes and Obesity

Being overweight increases the chances of developing the common type of diabetes, type 2 diabetes. In this disease, the body makes enough insulin but the cells in the body have become resistant to the salutary action of insulin. Science proposes that being overweight stresses the insides of individual cells. Specifically, overeating stresses the membranous network inside of cells called endoplasmic reticulum (ER). Most patients with type 2 diabetes are obese, and the global epidemic of obesity largely explains the dramatic increase in the incidence and prevalence of type 2 diabetes over the past 20 years. Currently, over a third (34%) of U.S. adults are obese (defined as BMI >30 kg/m2), and over 11% of people aged ≥20 years have diabetes, a prevalence projected to increase to 21% by 2050. Reducing your body weight, by even a small amount, can help improve your body's insulin sensitivity and lower your risk of developing cardiovascular and metabolic conditions such as type 2 diabetes, heart disease and types of cancer.

Related Societies

The Endocrine Society of Australia, Australia; Endocrine Nurses' Society of Australia, Australia; Philippine Society of Endocrinology and Metabolism, Philippines; Saudi Diabetes and Endocrine Association, Saudi Arabia; Australian diabetics society, Australia; Syria Diabetes Association, Syria; Diabetes Association of Thailand, Thailand; The Diabetes Association of Trinidad and Tabago, Trindad and Tobago; Tunisian Diabetic Association, Tunisia; American Association of Clinical Endocrinologists, USA

Track 17: Metabolic Syndrome

The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. People with metabolic syndrome have a five-fold greater risk of developing type 2 diabetes. Up to 80% of the 200 million people with diabetes globally will die of cardiovascular disease. This puts metabolic syndrome and diabetes way ahead of HIV/AIDS in morbidity and mortality terms.

Related Societies

Track 18: Gestational Diabetes

During pregnancy – usually around the 24th week – many women develop gestational diabetes. Diabetes can be especially hard on women. The burden of diabetes on women is unique because the disease can affect both mothers and their unborn children. Expectant moms can help control gestational diabetes by eating healthy foods, exercising and, if necessary, taking medication. Controlling blood sugar can prevent a difficult birth and keep you and your baby healthy. Treating gestational diabetes can help both you and your baby stay healthy. You can protect your baby and yourself by taking action right away to control your blood glucose levels.

Related Societies

Track 19: Insulin Management

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. Glucose control, adverse effects, cost, adherence, and quality of life need to be considered when choosing therapy. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic control and preventing diabetes-related complications.

Related Societies

Track 20: Diabetes Myths and Statistics

There are many myths about diabetes that make it difficult for people to believe some of the hard facts – such as diabetes is a serious and potentially deadly disease. These myths can create a picture of diabetes that is not accurate and full of stereotypes and stigma. Diabetes is an economic burden estimated at 3 billion dollars per year in direct and indirect costs. Diabetes threatens those we love. It is lived—and battled—every day by real people and families. It is treated by knowledgeable and caring doctors, nurses, diabetes educators and other health care professionals. Scientific researchers dedicate their careers to improving diabetes treatments and finding a cure.

Related Societies

Track 21: Diabetes and Surgery

There is a rising incidence and prevalence of diabetes mellitus. About 50% of people with diabetes mellitus are unaware of their condition. Approximately 25% of all patients with diabetes undergoing surgery are undiagnosed on admission to hospital. Patients with diabetes have a higher risk of cardiovascular disease. Patients with diabetes have a higher perioperative risk. They are more likely because of their disease to require surgery and those undergoing surgery are likely to be less well controlled and to have complications from their diabetes. Surgeons and anaesthetists operating on patients with diabetes should be familiar with the risks attached to having diabetes, and to the particular risks of the particular surgery and of anaesthesia in patients with diabetes.

Related Societies

Track 22: Diabetes and Cardiovascular Diseases

People with diabetes have a higher chance of developing cardiovascular diseases. The term cardiovascular disease (CVD) includes heart disease, stroke and all other diseases of the heart and circulation. Blood vessels are damaged by high blood glucose levels, high blood pressure, smoking or high levels of cholesterol. A large body of epidemiological and pathological data documents that diabetes is an independent risk factor for CVD in both men and women. Because of the aging of the population and an increasing prevalence of obesity and sedentary life habits in the United Kingdom, the prevalence of diabetes is increasing. Thus, diabetes must take its place alongside the other major risk factors as important causes of cardiovascular disease (CVD).

Related Societies

Track 23: Diabetes Retinopathy

Diabetic retinopathy is caused by changes in the blood vessels of the retina. When these blood vessels are damaged, they may leak blood and grow fragile new vessels. When the nerve cells are damaged, vision is impaired. These changes can result in blurring of your vision, hemorrhage into your eye, or, if untreated, retinal detachment. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness. People with untreated diabetes are 25 times more at risk for blindness than the general population. The longer a person has had diabetes, the higher the risk of developing diabetic retinopathy. Fortunately, with regular, proper primary eye care and treatment when necessary, the incidence of severe vision loss has been greatly reduced.

Related Societies

Track 24: Diabetic Nephropathy

Diabetic nephropathy is damage to your kidneys caused by diabetes. In severe cases it can lead to kidney failure. The kidneys have many tiny blood vessels that filter waste from your blood. High blood sugar from diabetes can destroy these blood vessels. Over time, the kidney isn't able to do its job as well. Later it may stop working completely. This is called kidney failure. There are no symptoms in the early stages. So it's important to have regular urine tests to find kidney damage early. Sometimes early kidney damage can be reversed. The problem is diagnosed using simple tests that check for a protein called albumin in the urine.

Related Societies

About the Conference:

With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 16^th Global Diabetes Conference & Medicare Expo (Diabetes Global 2017) as a continuum of our previous successful conference. Diabetes Global 2017 will be held in Rome, Italy during March 22-23, 2017. The conference will focus on Applying Science and Technology to Fight Diabetes.

This conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring radical new approaches. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc.

For more details, please visit: http://globaldiabetes.conferenceseries.com/europe

Importance & Scope:

The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years1. WHO projects that diabetes will be the 7th leading cause of death in 2030.

Diabetes Global 2017 will feature the latest developments in research, diagonosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Why Italy?

The prevalence of diabetes as well as glucose intolerance is greater in men and in the regions of the Center and South of Italy. The prevalence of diabetes has doubled in Italy over the past decade and now affects about 3 million people. In Italy, the prevalence of diabetes is 6.6% among people over 20 years old, The Italian Ministry of Health estimates that the number of total undiagnosed cases of diabetes is approximately 2 million. By 2013, the number of cases of both type 1 and type 2 are expected to rise to about 2.7 million and 4 million, respectively. Current diabetes incidence ranges from 4 to 10 new cases per 100,000 inhabitants annually throughout most of the country, but is as high as 35 new cases per 100,000 in Sardinia. Approximately 15,000 new cases of type 1 diabetes and 185,000 new cases of type 2 diabetes are diagnosed nationwide each year, resulting in a and a type 1:type 2 ratio of 1:9. One recent study by the Associazione Medici Diabetologi (AMD, the Italian Association of Diabetes Doctors) found that the number of cases of both type 1 and type 2 diabetes is increasing at about 1% and 7-10% per year, likely due in part to improved screening measures and an increase in obesity and sedentary lifestyles. Reflecting this imperative Diabetes Global-2017 aims to educate pediatricians and achieve the goal of reducing infant mortality rate.

Societies Associated with Diabetes Research

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Association National Italian Diabetic Athletes

Italian Society of Diabetology

International Diabetes Federation- Italy

Primary Care Diabetes Society

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedical Diabetes Research

Immunology Of Diabetes Society

American Association of Diabetes Educators

American Diabetes Association

The Asian Association For The Study Of Diabetes

International Association of the Diabetes and Pregnancy Study Groups

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Canadian Diabetes Association

Market Value on Diabetic Research:

The impact of diabetes on the individual quality of life and general economy in Italy is substantial. Healthcare costs for patients with diabetes in Italy are estimated at approximately €5.5 billion annually, representing more than 6% of total national healthcare spending. The Cost of Diabetes in Europe—Type 2 Study(CODE-2), which measured the total healthcare costs for patients with type 2 diabetes in 8 European countries (Italy, Belgium, France, Germany, Netherlands, Spain, Sweden, and UK), found the total yearly (1998) costs for people with type 2 diabetes in Italy alone to be almost €5.2 billion, a per-patient expenditure of at least €2900. Among patients with type 2 diabetes in Italy examined by the CODE-2 study, 17.8% were hospitalized during the 6 month study, with an average hospital stay of 13 days. The cost of hospitalizations accounted for the greatest portion of total costs for all countries in the study, at 55%, leading non-antidiabetic drugs (21%), outpatient care (18%) and antidiabetic drugs (7%).[3] Among non-antidiabetic drugs, the majority were cardiovascular and lipid-lowering (42%).[3] Annual per-patient costs vary widely with primary treatment type, with the highest per-patient costs accrued by those treated with diet and exercise alone.

Market Growth of Diabetic Research in the Last and Upcoming Ten Years

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 22-23, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

16^th Global Diabetes Conference and Medicare Expo March 22-23, 2017 Rome, Italy

Recommended Global Diabetes & Endocrinology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Diabetes Global 2017

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Useful Links

Special Issues